Q BioMed Inc. (QBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Oct 17, 2024, 4:00 PM EDT

Q BioMed Cash Flow Statement

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
TTM FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2017 - 2014
Period Ending
Feb '23 Nov '22 Nov '21 Nov '20 Nov '19 Nov '18 2017 - 2014
Net Income
-0.49-2.05-8.24-13.49-10.28-9.27
Upgrade
Depreciation & Amortization
0.050.050.050.050.05-
Upgrade
Other Amortization
0.770.920.410.1410.13
Upgrade
Stock-Based Compensation
0.770.92.346.572.52.65
Upgrade
Other Operating Activities
-0.360.370.350.180.930.09
Upgrade
Change in Accounts Receivable
0.030.07-0.08-0.09--
Upgrade
Change in Accounts Payable
1.191.470.840.571.41-0.07
Upgrade
Change in Other Net Operating Assets
0.230.210.04-0.160.290.02
Upgrade
Operating Cash Flow
2.181.94-4.3-6.23-4.11-6.45
Upgrade
Sale (Purchase) of Intangibles
------0.5
Upgrade
Investment in Securities
-3.14-3.14----
Upgrade
Investing Cash Flow
-3.14-3.14----0.5
Upgrade
Short-Term Debt Issued
-0.653.491.97--
Upgrade
Long-Term Debt Issued
----0.973.87
Upgrade
Total Debt Issued
0.760.653.491.970.973.87
Upgrade
Short-Term Debt Repaid
---0.03---
Upgrade
Total Debt Repaid
---0.03---
Upgrade
Net Debt Issued (Repaid)
0.760.653.461.970.973.87
Upgrade
Issuance of Common Stock
-0.11.010.320.624.95
Upgrade
Other Financing Activities
0.090.16----
Upgrade
Financing Cash Flow
0.850.914.476.241.598.81
Upgrade
Net Cash Flow
-0.38-0.290.170-2.511.86
Upgrade
Free Cash Flow
2.181.94-4.3-6.23-4.11-6.45
Upgrade
Free Cash Flow Margin
1041.64%682.75%-2199.44%-20778.14%--
Upgrade
Free Cash Flow Per Share
0.030.04-0.16-0.28-0.27-0.47
Upgrade
Cash Interest Paid
--0-0.03-
Upgrade
Levered Free Cash Flow
1.960.53-1.37-2.05-0.82-3.51
Upgrade
Unlevered Free Cash Flow
1.970.47-1.46-2.01-0.91-3.54
Upgrade
Change in Net Working Capital
-2.85-1.67-0.770.42-1.560.05
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.